Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Tetraphase Pharmaceuticals Company Profile (NASDAQ:TTPH)

Consensus Ratings for Tetraphase Pharmaceuticals (NASDAQ:TTPH) (?)
Ratings Breakdown: 1 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $18.83 (86.65% upside)

Analysts' Ratings History for Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/3/2014Brean CapitalInitiated CoverageBuy$23.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2014Needham & Company LLCBoost Price TargetBuy$15.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014BarclaysBoost Price TargetOverweight$16.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
11/13/2013GuggenheimInitiated CoverageBuy$25.00ViewTweet This Rating  Share This Rating on StockTwits
10/2/2013Ladenburg ThalmannBoost Price TargetBuy$13.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2013JMP SecuritiesBoost Price TargetMarket Outperform$12.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2013Needham & Company LLCReiterated RatingBuy$12.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
9/30/2013WBB SecuritiesInitiated CoverageSpeculative BuyViewTweet This Rating  Share This Rating on StockTwits
8/21/2013Ladenburg ThalmannInitiated CoverageBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2013JMP SecuritiesInitiated CoverageOutperform$12.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2013BMO Capital MarketsInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
4/15/2013Stifel NicolausInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2013BarclaysInitiated CoverageOverweight$16.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2013Needham & Company LLCInitiated CoverageBuy$12.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/25/2012 forward)